Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA

Journal of Viral Hepatitis

Volumn 12, Issue 3, 2005, Pages 236-242

  Ren, X R ^a,b   Zhou, L J ^a   Luo, G B ^c   Lin, B ^a   Xu, Anlong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b 458th Hospital of PLA   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2.2.15 cell; Hepatitis B virus; RNA interference; shRNA; U6 promoter

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; SHORT HAIRPIN RNA; VIRUS DNA; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CULTURE MEDIUM; DNA DETERMINATION; DNA REPLICATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA VECTOR; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA REPLICATION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 18344394782     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00587.x     Document Type: Article

References (41)

1. Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 6: 764-772.
2. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
3. Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335-1340.
4. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454.
5. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunisation: an economic analysis of current recommendations. JAMA 1995; 264: 1201-1208.
6. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13 (Suppl. 1): 47-49.
7. Ju ZY. An epidemiological study on the distribution of HBsAg and Anti-HBs in China. Chin J Microbiol Immunol 1986; 11(Suppl.): 20-40.
8. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
9. Hoognagle JH. Therapy of viral hepatitis. Digestion 1998; 59: 563-578.
10. Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339: 61-68.
11. Gregory JH. RNA interference. Nature 2002; 418: 244-251.
12. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
13. Kumar M, Carmichael GG. Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol Mol Biol Rev 1998; 62: 1415-1434.
14. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998; 67: 227-264.
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
16. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
17. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99: 6047-6052.
18. Aboobaker AA, Blaxter ML. Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi. Mol Biochem Parasitol 2003; 129: 41-51.
19. Kamath RS, Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 2003; 30: 313-321.
20. Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 2003; 21: 559-561.
21. Caplen NJ. RNAi as a gene therapy approach. Expert Opin Biol Ther 2003; 3: 575-586.
22. Lee NS, Dohjima T, Bauer G et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002; 20: 500-505.
23. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002; 418: 435-438.
24. Novina CD, Murray MF, Dykxhoorn DM et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8: 681-686.
25. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002; 418: 38-39.
26. Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 2003; 100: 2014-2018.
27. Yokota T, Sakamoto N, Enomoto N et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 2003; 4: 602-608.
28. Li H, Li WX, Ding SW. Induction and suppression of RNA silencing by an animal virus. Science 2002; 296: 1319-1321.
29. Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002; 12: 1301-1311.
30. Adelman ZN, Sanchez-Vargas I, Travanty EA et al. RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome. J Virol 2002; 76: 12925-12933.
31. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418: 430-434.
32. Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003; 37: 764-770.
33. Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 2003; 543: 51-54.
34. McCaffrey AP, Nakai H, Pandey K et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003; 21: 639-644.
35. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987; 84: 1005-1009.
36. Ding J, Liu J, Xue CF, Gong WD, Li YH, Zhao Y. Anti-HBV effect of TAT- HBV targeted ribonuclease. World J Gastroenterol 2003; 9: 1525-1528.
37. Romero MR, Martinez-Diez MC, Larena MG et al. Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system. Antivir Chem Chemother 2002; 13: 371-380.
38. Liu J, Li YH, Xue CF et al. Targeted ribonuclease can inhibit replication of hepatitis B virus. World J Gastroenterol 2003; 9: 295-299.
39. Tan TM, Zhou L, Houssais S et al. Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozyme. Antisense Nucleic Acid Drug Dev 2002; 12: 257-264.
40. Sood RK, Bhadti VS, Fattom AI et al. Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells. Antiviral Res 2002; 53: 159-164.
41. Ying C, De Clercq E, Neyts J. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. J Viral Hepat 2000; 7: 79-83.